A few words about us...

For more than three decades, the Technomark name has been synonymous with global development. Established in 1987 in London for strategic planning to large pharma, today Technomark is an international life science investment group who has successfully merged its product development and venture capital backgrounds, through proactive Management.

Our investment track record started in 2000 with our first (and only) venture capital fund in which we invested in 8 life science companies (4 drug delivery/med-tech; 4 therapeutic), of which we successfully exited 7 of the companies. (Please click here for a summary of Fund I)

Since 2009 under our co-funding business model, we share the risk and the cost of clinical studies in exchange for some downstream remuneration. Through our small and hand-selected network of boutique clinical CROs around the world, we invest by co-funding clinical trials, which allows us to be more involved as investors, strategists, and partners, or just first-hand observers.